RAPPRapport Therapeutics, Inc.

$45.98

What is the market doing?

What the tape says about RAPP

Rapport Therapeutics, Inc. is +215% over the past year while the S&P 500 is +20%: 195 points ahead of the market.

+215%

1-year return · S&P 500 +20%

vs 200-day average
+36%

vs 200-day average · a clear uptrend

RSI (14)
41

RSI (14) · neutral

Below its 52-week high
12%

Below its 52-week high

2024-08-15$7.15 – $52.44 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$45.98
1 monthS&P 500 −0.30%
−0.84%
1 yearS&P 500 +20%
+215%
vs 50-day average$43.47
+5.8%
52-week high
$52.44
52-week low
$14.24
Annualised volatility
120%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$341K
Calendar-year price return
YearReturn
2026 (year to date)+52%
2025+71%
Average return by calendar month, 2024–2026
MonthYearsPositiveAverage
Jan20 of 2−9.9%
Feb21 of 2−15%
Mar21 of 2+3.9%
Apr22 of 2+10%
May21 of 2−4.3%
Jun21 of 2+18%
Jul32 of 3+11%
Aug32 of 3+12%
Sep31 of 3+19%
Oct21 of 2+8.6%
Nov21 of 2−2.1%
Dec21 of 2−10%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.